Atlas Trials

A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11)

Clinical trial NCT05755737 · RECRUITING

Trial details

NCT number
NCT05755737
Sponsor
University of Calgary
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Vasovagal Syncope (VVS)Syncope
Start date
2023-06-01
Primary completion
2025-12-31
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.